206 related articles for article (PubMed ID: 27589736)
1. β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer.
Yin HL; Wu CC; Lin CH; Chai CY; Hou MF; Chang SJ; Tsai HP; Hung WC; Pan MR; Luo CW
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589736
[TBL] [Abstract][Full Text] [Related]
2. 3,4-Methylenedioxy-β-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing β1 integrin function and surface protein disulfide isomerase.
Chen IH; Chang FR; Wu YC; Kung PH; Wu CC
Biochimie; 2015 Mar; 110():81-92. PubMed ID: 25593085
[TBL] [Abstract][Full Text] [Related]
3. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
[TBL] [Abstract][Full Text] [Related]
4. Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.
Ou-Yang F; Pan MR; Chang SJ; Wu CC; Fang SY; Li CL; Hou MF; Luo CW
Life Sci; 2019 Dec; 238():116963. PubMed ID: 31639396
[TBL] [Abstract][Full Text] [Related]
5. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
[TBL] [Abstract][Full Text] [Related]
6. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
[TBL] [Abstract][Full Text] [Related]
7. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
[TBL] [Abstract][Full Text] [Related]
8. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells.
Taliaferro-Smith L; Oberlick E; Liu T; McGlothen T; Alcaide T; Tobin R; Donnelly S; Commander R; Kline E; Nagaraju GP; Havel L; Marcus A; Nahta R; O'Regan R
Oncotarget; 2015 Mar; 6(7):4757-72. PubMed ID: 25749031
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
10. β1 integrin inhibition elicits a prometastatic switch through the TGFβ-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer.
Truong HH; Xiong J; Ghotra VP; Nirmala E; Haazen L; Le Dévédec SE; Balcioğlu HE; He S; Snaar-Jagalska BE; Vreugdenhil E; Meerman JH; van de Water B; Danen EH
Sci Signal; 2014 Feb; 7(312):ra15. PubMed ID: 24518294
[TBL] [Abstract][Full Text] [Related]
11. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
[TBL] [Abstract][Full Text] [Related]
12. E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer.
Chen HA; Chang YW; Tseng CF; Chiu CF; Hong CC; Wang W; Wang MY; Hsiao M; Ma JT; Chen CH; Jiang SS; Wu CH; Hung MC; Huang MT; Su JL
Ann Surg Oncol; 2015 Mar; 22(3):889-98. PubMed ID: 25212833
[TBL] [Abstract][Full Text] [Related]
13. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.
Jin XX; Mei YN; Shen Z; Zhu JF; Xing SH; Yang HM; Liang G; Zheng XH
Phytomedicine; 2022 Jul; 101():154087. PubMed ID: 35429924
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of focal adhesion kinase and paxillin to beta1 integrin promotes cancer cell migration via mitogen activated protein kinase activation.
Crowe DL; Ohannessian A
BMC Cancer; 2004 May; 4():18. PubMed ID: 15132756
[TBL] [Abstract][Full Text] [Related]
15. Integrin beta1-mediated signaling is involved in transforming growth factor-beta2-promoted migration in human lens epithelial cells.
Yao K; Tan J; Ye P; Wang K; Xu W; ShenTu X; Tang X
Mol Vis; 2007 Sep; 13():1769-76. PubMed ID: 17960115
[TBL] [Abstract][Full Text] [Related]
16. FAK tyrosine 407 organized with integrin αVβ5 in Hs578Ts(i)8 advanced triple-negative breast cancer cells.
Payan I; McDonnell S; Torres HM; Steelant WF; Van Slambrouck S
Int J Oncol; 2016 May; 48(5):2043-54. PubMed ID: 26984508
[TBL] [Abstract][Full Text] [Related]
17. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling.
Shen M; Jiang YZ; Wei Y; Ell B; Sheng X; Esposito M; Kang J; Hang X; Zheng H; Rowicki M; Zhang L; Shih WJ; Celià-Terrassa T; Liu Y; Cristea I; Shao ZM; Kang Y
Cancer Cell; 2019 Jan; 35(1):64-80.e7. PubMed ID: 30612941
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway.
van Seventer GA; Salmen HJ; Law SF; O'Neill GM; Mullen MM; Franz AM; Kanner SB; Golemis EA; van Seventer JM
Eur J Immunol; 2001 May; 31(5):1417-27. PubMed ID: 11465098
[TBL] [Abstract][Full Text] [Related]
19. An EGFR/Src-dependent β4 integrin/FAK complex contributes to malignancy of breast cancer.
Tai YL; Chu PY; Lai IR; Wang MY; Tseng HY; Guan JL; Liou JY; Shen TL
Sci Rep; 2015 Nov; 5():16408. PubMed ID: 26549523
[TBL] [Abstract][Full Text] [Related]
20. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]